| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Eur J Cardiothorac Surg 2007;32:462-468. doi:10.1016/j.ejcts.2007.06.009
Copyright © 2007, European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved
a The Division of Cardiology, Department of Pediatrics, University of Toronto, The Hospital for Sick Children, Toronto, Ontario, Canada
b The Division of Cardiology, Department of Medicine, University of Toronto, Toronto Congenital Cardiac Center for Adults, Toronto General Hospital, Toronto, Ontario, Canada
c The Division of Cardiovascular Surgery, Department of Surgery, University of Toronto, The Hospital for Sick Children, Toronto, Ontario, Canada
Received 21 February 2007; received in revised form 22 May 2007; accepted 11 June 2007.
* Corresponding author. Address: The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, Canada M5G 1X8. Tel.: +1 416 813 7610; fax: +1 416 813 7547. (Email: brian.mccrindle{at}sickkids.ca).
Objective: While there are no controlled studies, pulmonary valve replacement (PVR) after late tetralogy of Fallot repair is performed for patients with symptoms, arrhythmia or ventricular dysfunction. We sought to determine the impact of PVR on clinical outcomes. Methods: In a matched cohort study, 82 patients with PVR after tetralogy of Fallot repair without a history of ventricular arrhythmia were matched and compared with similarly followed non-PVR control subjects. A propensity-score adjusted analysis using repeated measures regression techniques was performed. Results: For the PVR subjects, the mean age was 28 years with a mean duration follow-up of 9 years. Before PVR, these subjects were significantly more likely than matched non-PVR subjects to have had non-ventricular arrhythmias, symptoms, lower functional class, longer QRS duration, lower right ventricular ejection fraction and higher right ventricular pressure, and reduced exercise duration but not aerobic capacity. During follow-up, sudden death occurred in four non-PVR subjects compared with no PVR subjects, with three episodes of ventricular tachycardia in the PVR subjects versus none in the non-PVR subjects (p = 0.49). Symptoms and functional class improved in the PVR subjects with no change in the non-PVR subjects (p < 0.001). The change in QRS duration was not significantly different between PVR and non-PVR subjects (p = 0.48). Oxygen consumption at peak exercise did not significantly change in either group. For PVR subjects, there was a significant qualitative reduction in pulmonary (p < 0.001) and tricuspid valve regurgitation (p = 0.009) and right ventricular size (p < 0.001) and dysfunction (p < 0.001) noted on echocardiography. Conclusions: Symptoms and functional status are improved after late PVR, with a reduction in pulmonary and tricuspid valve regurgitation and right ventricular size and dysfunction. While a significant impact on arrhythmia was not detected, there were no sudden deaths in the PVR subjects.
Key Words: Tetralogy of Fallot • Pulmonary valve • Arrhythmia • Sudden death • Health status
This article has been cited by other articles:
|
|
 |
|
  D. M. Harrild, C. I. Berul, F. Cecchin, T. Geva, K. Gauvreau, E. P. Walsh, and F. Pigula Response to Letter Regarding Article, "Pulmonary Valve Replacement in Tetralogy of Fallot: Impact on Survival and Ventricular Tachycardia" Circulation, September 8, 2009; 120(10): e80 - e80. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Adamson, H. A. Vohra, and M. P. Haw Does pulmonary valve replacement post repair of tetralogy of Fallot improve right ventricular function? Interactive CardioVascular and Thoracic Surgery, September 1, 2009; 9(3): 520 - 527. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Wald, I. Haber, R. Wald, A. M. Valente, A. J. Powell, and T. Geva Effects of Regional Dysfunction and Late Gadolinium Enhancement on Global Right Ventricular Function and Exercise Capacity in Patients With Repaired Tetralogy of Fallot Circulation, March 17, 2009; 119(10): 1370 - 1377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Harrild, C. I. Berul, F. Cecchin, T. Geva, K. Gauvreau, F. Pigula, and E. P. Walsh Pulmonary Valve Replacement in Tetralogy of Fallot: Impact on Survival and Ventricular Tachycardia Circulation, January 27, 2009; 119(3): 445 - 451. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Hickey, G. Veldtman, T. J. Bradley, A. Gengsakul, C. Manlhiot, W. G. Williams, G. D. Webb, and B. W. McCrindle Late risk of outcomes for adults with repaired tetralogy of Fallot from an inception cohort spanning four decades Eur. J. Cardiothorac. Surg., January 1, 2009; 35(1): 156 - 164. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. K. Bodhey, P. Beerbaum, S. Sarikouch, S. Kropf, P. Lange, F. Berger, R. H. Anderson, and T. Kuehne Functional Analysis of the Components of the Right Ventricle in the Setting of Tetralogy of Fallot Circ Cardiovasc Imaging, September 1, 2008; 1(2): 141 - 147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Lurz, L. Coats, S. Khambadkone, J. Nordmeyer, Y. Boudjemline, S. Schievano, V. Muthurangu, T. Y. Lee, G. Parenzan, G. Derrick, et al. Percutaneous Pulmonary Valve Implantation: Impact of Evolving Technology and Learning Curve on Clinical Outcome Circulation, April 15, 2008; 117(15): 1964 - 1972. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
